Head-to-head · WeighScore
Mint Medical Clinic vs NexLife
The verdict
NexLife takes it — 68.7/100 to 55.7/100.
NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Mint Medical Clinic | NexLife |
|---|---|---|
| WeighScore | 55.7/100 | 68.7/100 |
| Grade | C | C |
| Scorecard rank | #433 | #139 |
| Semaglutide | $299/mo (compounded) | $165/mo (compounded) |
| Tirzepatide | $299/mo (compounded) | $215/mo (compounded) |
| Coverage | 1 state | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #433 · C
Strengths
- Hybrid model with an in-person consultation option for patients who prefer physical care
- Parent practice disclosed (Balance Medical Clinic)
- Physical Utah clinic addresses listed on the homepage
- $299/mo flat starting price, competitive with national DTC providers
- Broader scope (sexual health, hormones) may suit patients wanting integrated care
Where it loses points
- Utah only for in-person; telehealth states served not disclosed
- Pharmacy partner not disclosed
- LegitScript certification not mentioned
- 503A vs 503B compounding designation not disclosed
- No named medical director on the homepage
Graded #139 · C
Strengths
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
Where it loses points
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.